4th Quarter - Report

POLICY ADVOCATES for GLAXOSMITHKLINE

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Monitor Patent issues

LobbyistCovered position, as disclosed
VICTOR CABRAL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Administration for Children & Families (ACF)

Health Issues HCR

Obamacare Repeal Health Care reform Chip Reauthorization

LobbyistCovered position, as disclosed
VICTOR CABRAL —

Contacted: Administration for Children & Families (ACF); SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

Corporate Tax Reform Alternative minimum Tax reform Excise Tax Issues Health Care Extenders

LobbyistCovered position, as disclosed
VICTOR CABRAL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Administration for Children & Families (ACF)

Trade (domestic/foreign) TRD

USTR appointments Patent Protection NAFTA repeal and Renegotiation

LobbyistCovered position, as disclosed
VICTOR CABRAL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Administration for Children & Families (ACF)

Medicare/Medicaid MMM

Health Care Reform Legislation HR1628 Access to Affordable Prescription Drugs Medicare Prescription Drug Price Negotiation Act HR 242 Protecting Medicare from executive Action S 251 Medicare Prescription Drug Price Negotiation Act S 41 Race for Children Act HR 1231

LobbyistCovered position, as disclosed
VICTOR CABRAL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Administration for Children & Families (ACF)

Bills named: H.R. 242 (115th), H.R. 1628 (115th), H.R. 1231 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.